Biostage, Inc. Stock Price - BSTG

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
Biostage, Inc. (QB) BSTG OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.13 -5.24% 2.35 2.35 2.35 2.35 2.48 09:30:03
Bid Price Ask Price Spread Spread % News
2.50 2.90 0.40 13.79% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 260 $ 2.35 $ 611 1,959 0.75 - 3.30
Last Trade Time Type Quantity Stock Price Currency
11:31:16 50 $ 2.50 USD

Biostage, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 17.89M 7.61M $ -7.53M - - 2.78M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
9.57k $ - 0.00% - -

more financials information »

Biostage, Inc. News

Loading Messages....

Latest BSTG Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BSTG Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week22.522.40252k0.3517.50%
1 Month2.76322.50382k-0.41-14.86%
3 Months2.18322.47392k0.177.80%
6 Months2.2530.752.32503k0.14.44%
1 Year2.93.30.752.38073k-0.55-18.97%
3 Years0.14185.850.05260.1989100k2.20821,557.26%
5 Years0.14185.850.05260.1989100k2.20821,557.26%

Biostage, Inc. Description

Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology combines the synthetic scaffold with tissue engineering and cell biology to create method of addressing organ damage. Its Cellframe technology stimulates the body's signaling pathways and natural healing process to regenerate and restore organ function. The company is developing organ implants as a platform of being used in the esophagus, trachea, and bronchi. Its implants are being advanced and tested in preclinical collaborative studies with Mayo Clinic and Connecticut Children's Medical Center. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2012 and is headquartered in Holliston, Massachusetts.


Your Recent History
USOTC
BSTG
Biostage, ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.